The experimental study of anti-inflammatory properties of the drug “Diclocor”
DOI:
https://doi.org/10.24959/cphj.15.1363Keywords:
Diclocor, diclofenac, quercetin, inflammationAbstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used groups of medicines. Despite the undeniable clinical effectiveness, their use is associated with the risk of side effects. This fact directs scientific research to searching combinations of NSAIDs with other substances in order to identify compositions which will allow reducing the dose of the NSAID without losing its anti-inflammatory effectiveness. In view of all this, a new combined drug “Diclocor” developed by “Borshchahivskiy CPP” (Ukraine) is of interest. The article presents the results of the experimental study of the anti-inflammatory effect of the combined drug “Diclocor” in comparison with its active monocomponents – diclofenac sodium and quercetin. The alterative stage of inflammation was studied on the model of scarified wounds, the exudative stage – on the model of carrageenin edema, and the proliferative stage – on the model of cotton pellet-induced granuloma. All studies were conducted in rats. The experimental results have shown the superiority of Diclocor in influencing on all three stages of inflammation compared to the reference drugs in the appropriate doses. Diclocor has exhibited the most pronounced effect on the stages of alteration and exudation, and can be described as a promising drug for the treatment of proliferative and destructive inflammatory diseases.
References
Коваленко В.М., Борткевич О.П., Проценко Г.О. Нестероидные противовоспалительные препараты: роль и место в современной ревматологической практике на основании доказательной медицины // Украинский ревматологический журнал.– 2006.– Т. 23, № 1.– С. 17-29.
Ковалев В.Б., Ковган В.В., Колчина Е.Ю. Механизмы лечебного действия биофлавоноида кверцетина (обзор литературы) // Український медичний аль-манах.– 1999.– Т. 2, № 4.– С. 176-182.
Лапач С.Н. Статистические методы в медико-биологических исследовани-ях с использованием Excel // С. Н. Лапач, А. В. Чубенко, П. Н. Бабич.– К.: Морион, 2000.– 320 с.
Миронов А.Н., Бунатян Н.Д. и др. Руководство по проведению доклиниче-ских исследований лекарственных средств. Часть первая.– М.: Гриф и К, 2012.– 944 с.
Прозоровский В.Б. Практическое пособие по ускоренному определению средних эффективных доз и концентрации биологически активных веществ // Прозоровский. В.Б.– СПб, 1992. – 42 с.
Стефанова А.В. Доклинические исследования лекарственных средств: Методические рекомендации // Под ред. Стефанова. А.В.– К: Авиценна, 2002.– 528 с.
Стефанов О., Бухтіарова Т., Коваленко В. та ін. Настанова СТ-Н МОЗУ 42-6.0:2008. Лікарські засоби. Належна лабораторна практика (видання офіційне) // К.: Моріон, 2009.– С. 37-68.
Chi-Yu Y., Su-Lan H., Kuo-Ching W. et al. Bioavailability and Metabolitic Pharmacokinetics of Rutin and Quercetin in Rats // Journal of Food and Drug Analysis.– 2005.– Vol. 13.– P. 244-250.
Das N. et al. Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice // Food & Function.– 2013.– Vol. 4(6). – P. 889–898. Available at: http://dx.doi.org/10.1039/C3FO30241E.
Gardi C. et al. Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis // Archives of biochemistry and biophysics. – 2015. – Vol. 583. – P. 150–157.
Marcolin E. et al. Quercetin Treatment Ameliorates Inflammation and Fibrosis in Mice with Nonalcoholic Steatohepatitis. The Journal of Nutrition.– 2012.– Vol. 142(10) .– P.1821–1828.
Rogerio A.P. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma // Inflamm. Res.– 2007.– Vol. 56.– P. 402-408.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
